Research study · Alzheimer's & Dementia: Translational Research & Clinical Interventions · 2026
Person‐centered intervention response in primary progressive aphasia: A secondary analysis of the Communication Bridge‐2 randomized clinical trial
Verified on PubMed Oxford CEBM Level 1B: Randomized Controlled Trial
A 2026 randomized controlled trial in Alzheimer's & Dementia: Translational Research & Clinical Interventions tested cannabinoids in aphasia. The results were encouraging, but this study cannot tell us whether the therapy was better than other options. This study suggests that personalized, goal-focused speech therapy can help people with this kind of language loss meet the.
In plain language
Study overview
This study looked at people who have a condition that slowly takes away their ability to find and use words, along with a family member or close friend who helps them communicate. All of them took part in a personalized speech therapy program that focused on the everyday communication goals they chose for themselves, such as talking with family or using the phone. The researchers then checked how well each person met those personal goals afterward and a year later.
Findings
The results were encouraging, but this study cannot tell us whether the therapy was better than other options. Every person in the study made progress on at least one of their personal goals at some point, and most of the goals were still being met a year later.
Explore Dr. Caplan's interactive tool detailing cytochrome P450 pathways, clinical titration intervals, and physician surveillance rules.
The deeper readScientific analysis
INTRODUCTION: Person-centered outcomes that capture clinically meaningful change are essential to non-pharmacological intervention research for Alzheimer's disease and related dementias. Primary progressive aphasia (PPA) is a neurodegenerative syndrome characterized by progressive language impairment. The Communication Bridge-2 (CB2) randomized controlled trial previously demonstrated the efficacy of a personalized, participation-focused speech-language intervention on Goal Attainment Scaling (GAS), a person-centered communication participation outcome. This secondary responder analysis characterized meaningful participant- and goal-level response following intervention and at 12 months after enrollment to inform clinical translation and future appropriate use criteria. METHODS: Fifty participants with mild to moderate PPA in the CB2 experimental arm, each with three individualized communication participation goals (N = 150 goals), were included. Prespecified responder thresholds were defined as GAS ≥1 following each intervention block and GAS ≥0 at 12 months. Descriptive analyses examined responder patterns across time points, participants, baseline severity, PPA subtypes, and goal characteristics. RESULTS: All participants met responder criteria at one or more evaluation time points. At 12 months, 79% of goals met responder criteria, and 60% of participants met responder criteria across all three goals. More than half of the goals (51.3%) met responder criteria at all three evaluation time points. Exploratory patterns suggested higher 12-month responder rates for goals targeting speech, familiar communication partners, and familiar communication contexts. DISCUSSION: This secondary responder analysis demonstrates that a person-centered, participation-focused speech-language intervention was associated with meaningful goal-level improvement or maintenance across a heterogeneous PPA population, with many responses sustained over 12 months.
The paper
Citation
Rogalski E, Fegter O, Roberts AC, Bona M, Cummings E, Esparza M, et al. Person‐centered intervention response in primary progressive aphasia: A secondary analysis of the Communication Bridge‐2 randomized clinical trial. Alzheimer's & Dementia: Translational Research & Clinical Interventions (2026). PubMed 42358427 · DOI
Limitations the authors noted
Analysis restricted to experimental arm; no causal inference or comparative effectiveness. Moderate sample size; findings descriptive and hypothesis-generating. No control-arm comparison. Response thresholds chosen on clinical grounds; alternatives may change classification. Restricted to mild to moderate PPA with a willing communication partner; limited generalizability. Complete-case analysis without imputation after six participants excluded for missing data.
In practice
Why this matters
This study suggests that personalized, goal-focused speech therapy can help people with this kind of language loss meet the everyday communication goals that matter most to them, and that some gains last a year. It does not show that the therapy works better than other approaches, and it only looked at people who received it, with a fairly small group and no comparison group. It leaves open how the results would apply to people with more advanced disease, other forms of treatment, and longer periods of time.
Frequently asked questions
Clinical Questions & Answers
What were the primary clinical findings regarding Cannabinoids and Aphasia?
The results were encouraging, but this study cannot tell us whether the therapy was better than other options. Every person in the study made progress on at least one of their personal goals at some point, and most of the goals were still being met a year later.
What study limitations or clinical safeguards should patients keep in mind?
Analysis restricted to experimental arm; no causal inference or comparative effectiveness. Moderate sample size; findings descriptive and hypothesis-generating. No control-arm comparison.
Browse related research
Condition: Aphasia Condition: Dementia Topic: Cannabinoids
Related on CED Clinic
Back to Daily Research and Patient Questions
Reviewed by Dr. Caplan on October 20, 2026.
This page is general education about a published study. It is not medical advice and does not create a doctor-patient relationship. For care specific to you, book a consultation.
